Jun 7, 2017

For second straight day, no vote of confidence for Sessions

Like Sean Spicer on Tuesday, Sarah Sanders declined Wednesday to say President Trump has confidence in Jeff Sessions. It's stunning that for two consecutive days, the top White House press people can't say whether the President has confidence in his Attorney General.

Why this matters: It's not hard to find out whether the President has confidence in the A.G. Even if you accept the premise that Sanders couldn't speak directly to Trump, she could easily have asked somebody close to Trump, such as Hope Hicks, for an answer.

Another possibility: Trump has decided to publicly humiliate Sessions — leaving him hanging out unsupported for a while — as he did to Bannon and others when he was down on them.

Go deeper

GOP sees more hurdles for Trump as coronavirus crisis drags on

Photo: Alex Wong/Getty Images

Republicans are increasingly concerned not only about President Trump’s daily briefings but also his broader plan to ease the nation out of the virus crisis and back to work. This concern is acute — and spreading. 

Why it matters: Trump can easily address the briefing worries by doing fewer, but the lackluster bounce-back planning is what worries Republicans most. 

Pandemic forces startups to shift gears

Illustration: Eniola Odetunde/Axios

Spaces CEO Brad Herman had an early warning about COVID-19 because his startup supplies VR attractions to a number of theme parks in China. Realizing that the business he spent the last few years building was going to evaporate, Herman quickly found a new way to apply his team's know-how: helping companies host Zoom teleconferences in VR.

Why it matters: Many startups are rethinking the viability of their core businesses in the wake of the coronavirus. Spaces' move is one of many such pivots likely to crop up in the coming months.

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

Go deeperArrow2 hours ago - Health